Results 111 to 120 of about 21,803 (247)

Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double‐Blinded, Controlled ‘Split Body’ Clinical Trial

open access: yesVeterinary Dermatology, Volume 37, Issue 3, Page 427-436, June 2026.
ABSTRACT Background Targeted antimicrobial therapy for canine otitis externa (OE) represents an opportunity for antimicrobial stewardship. Fosmidomycin selectively inhibits the non‐mevalonate pathway for isoprenoid biosynthesis utilised by canine‐adapted, and not human‐adapted, staphylococci.
Lindsey E. Citron   +6 more
wiley   +1 more source

Evaluation of the Antimicrobial Activity of a 3% Chlorhexidine/Ophytrium Mousse and Shampoo in 18 Healthy Dogs

open access: yesVeterinary Dermatology, Volume 37, Issue 3, Page 345-352, June 2026.
Background: Topical antimicrobial therapy is vital for managing pyoderma yet poor compliance can affect treatment outcomes.Hypothesis/objective: To evaluate the antimicrobial activity of a 3% chlorhexidine/ophytrium shampoo at different contact times and the residual activity of a 3% chlorhexidine/ophytrium mousse against meticillin‐susceptible and ...
Matt McHale   +4 more
wiley   +1 more source

Restorative proctocolectomy with ileal pouch reservoir in ulcerative colitis : the first series from Malta [PDF]

open access: yes, 1991
Seventy five to eighty percent of patients with ulcerative colitis are more or less satisfactorily treated medically. Surgery cures the disease, but because proper surgical therapy has until recently necessitated a permanent ileostomy, physicians and ...
Gatt, Dennis
core  

Pyoderma Gangrenosum [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1970
R D, Peachey, G C, Wells
openaire   +2 more sources

Pyoderma Gangrenosum Masquerading as Chronic Infective Ulcers: Two Case Reports Across Age Extremes

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Pyoderma gangrenosum (PG) is a rare, ulcerative neutrophilic dermatosis that presents significant diagnostic challenges due to its clinical heterogeneity and lack of definitive laboratory markers. Misdiagnosis often leads to inappropriate treatments, delayed recovery, and increased morbidity.
Amrit Neupane   +4 more
wiley   +1 more source

Group C/G Streptococcal Pharyngitis and Acute Rheumatic Fever in Auckland, New Zealand, 2010–2016

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Jane Oliver   +3 more
wiley   +1 more source

Significant kidney impairment in pediatric inflammatory bowel disease and practice points for pediatric gastroenterologists

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 5, Page 1251-1260, May 2026.
Abstract Objectives Children with inflammatory bowel disease (IBD) have an increased risk of developing kidney disorders, which may cause significant kidney function impairment (SKI) or lead to chronic kidney disease (CKD). In this study we aimed to provide insights in causes and diagnoses of SKI cases and to provide recommendations for pediatric ...
Stephanie A. Vuijk   +16 more
wiley   +1 more source

Leukocytoclastic vasculitis and necrobiotic pulmonary nodules in endoscopic remission of ulcerative colitis

open access: yesJPGN Reports, Volume 7, Issue 2, Page 309-311, May 2026.
Abstract Skin and lung findings, including the rare findings of leukocytoclastic vasculitis (LCV) and necrobiotic pulmonary nodules, are known extraintestinal manifestations (EIMs) of inflammatory bowel disease. However, these rare EIMs have typically been reported as being a sign of active intestinal disease.
Joshua D. Noe   +3 more
wiley   +1 more source

Antimicrobial activity of an acetic and boric acid solution against Staphylococcus pseudintermedius [PDF]

open access: yes, 2009
Incubation of 101 colony forming units/ml of Staphylococcus pseudintermedius in an undiluted, a 1:2 and a 1:4 diluted aqueous 2% acetic acid and 2% boric acid solution resulted in inactivation of the bacteria within 30, 60 and 120 minutes, respectively ...
Baele, Margo   +4 more
core   +1 more source

Benralizumab for anti‐tumor necrosis factor‐associated eosinophilic gastrointestinal disease in a child with ileal Crohn's: A case report

open access: yesJPGN Reports, Volume 7, Issue 2, Page 312-314, May 2026.
Abstract Crohn's disease (CD) and eosinophilic gastrointestinal diseases (EGIDs) are distinct inflammatory entities, but eosinophilic disease may emerge as a paradoxical immune complication of anti–tumor necrosis factor therapy. We report a 12‐year‐old boy with terminal ileal CD who developed severe eosinophilic gastritis and ileitis, peripheral ...
Jonathan Dudzik   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy